Allianz Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-936,921
Closed -$93M 2934
2019
Q3
$93M Buy
936,921
+208,792
+29% +$19.8M 0.09% 245
2019
Q2
$67.3M Buy
728,129
+49,983
+7% +$4.75M 0.06% 339
2019
Q1
$64M Sell
678,146
-455,511
-40% -$39.8M 0.06% 334
2018
Q4
$72.7M Buy
1,133,657
+345,979
+44% +$25.5M 0.08% 274
2018
Q3
$70.5M Buy
787,678
+59,355
+8% +$5.25M 0.06% 332
2018
Q2
$57.8M Sell
728,323
-192,328
-21% -$16M 0.06% 357
2018
Q1
$82.1M Sell
920,651
-1,121,788
-55% -$108M 0.08% 284
2017
Q4
$213M Buy
2,042,439
+409,828
+25% +$46.2M 0.17% 115
2017
Q3
$238M Buy
1,632,611
+4,685
+0.3% +$638K 0.21% 91
2017
Q2
$212M Sell
1,627,926
-234,508
-13% -$28.7M 0.2% 90
2017
Q1
$232M Buy
1,862,434
+245,381
+15% +$29.4M 0.23% 72
2016
Q4
$187M Sell
1,617,053
-192,633
-11% -$21.5M 0.17% 133
2016
Q3
$188M Sell
1,809,686
-293,184
-14% -$31.7M 0.18% 116
2016
Q2
$207M Sell
2,102,870
-21,304
-1% -$2.2M 0.22% 91
2016
Q1
$213M Buy
2,124,174
+149,131
+8% +$15.4M 0.24% 84
2015
Q4
$237M Sell
1,975,043
-532,755
-21% -$61.6M 0.27% 74
2015
Q3
$271M Sell
2,507,798
-40,215
-2% -$4.99M 0.32% 60
2015
Q2
$295M Buy
2,548,013
+117,349
+5% +$13.4M 0.31% 67
2015
Q1
$280M Sell
2,430,664
-293,176
-11% -$35M 0.32% 71
2014
Q4
$305M Buy
2,723,840
+183,853
+7% +$19.4M 0.34% 65
2014
Q3
$241M Buy
2,539,987
+52,694
+2% +$4.76M 0.29% 74
2014
Q2
$214M Buy
2,487,293
+58,913
+2% +$4.48M 0.27% 80
2014
Q1
$170M Sell
2,428,380
-341,616
-12% -$27.1M 0.2% 111
2013
Q4
$234M Sell
2,769,996
-688,254
-20% -$54.5M 0.3% 76
2013
Q3
$267M Sell
3,458,250
-933,526
-21% -$65.4M 0.35% 69
2013
Q2
$257M Buy
+4,391,776
New +$264M 0.36% 64

Other funds holding CELG

Allianz Asset Management's CELG Position: Q4 2019 in Review

Allianz Asset Management sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 936,921 shares — an estimated $93M sold.

Allianz Asset Management first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $305M in Q4 2014. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Allianz Asset Management reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Allianz Asset Management sold 936,921 Celgene Corp shares in Q4 2019, an estimated $93M.
  • Allianz Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Allianz Asset Management's Celgene Corp position peaked at $305M in Q4 2014.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Allianz Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.